Safety and Efficacy of Immunomodulators and Biologics During Pregnancy and Lactation for the Treatment of Inflammatory Bowel Disease

Expert Opinion on Drug Safety - United Kingdom
doi 10.1517/14740338.2012.720970
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

Immunosuppressives and Biologics During Pregnancy and Lactation

Wiener Klinische Wochenschrift
Medicine
2019English

Treatment of Reflux Disease During Pregnancy and Lactation

Turkish Journal of Gastroenterology
Gastroenterology
2020English

Momordica Charantia (Bitter Melon): Safety and Efficacy During Pregnancy and Lactation

International Journal of Studies in Nursing
2018English

Thioguanine in Inflammatory Bowel Disease: Long-Term Efficacy and Safety

United European Gastroenterology Journal
OncologyGastroenterology
2016English

Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Safety and Efficacy of Parenteral Iron in Children With Inflammatory Bowel Disease

British Journal of Clinical Pharmacology
Pharmacology
2018English

Insights Into the Treatment of Inflammatory Bowel Disease in Pregnancy

Therapeutic Advances in Gastroenterology
Gastroenterology
2019English

Systematic Review and Meta-Analysis: Efficacy and Safety of Oral Janus Kinase Inhibitors for Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Preconception Care Reduces Relapse of Inflammatory Bowel Disease During Pregnancy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy